Today, two Republican Congressmen introduced the “Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act.” Representatives David Joyce (R-OH) Ohio and Don Young (R-AK) are the sponsors of the Act. Joyce and Young are also the current co-chairs of the bipartisan Congressional Cannabis Caucus. This Caucus was launched in 2017 by well-known cannabis advocates, former Rep. Dana Rohrabacher, (R-CA) Earl Blumenauer (D-OR), former Colorado Rep. and current Colorado Governor, Jared Polis, and the aforementioned Rep. Young. The Act would remove cannabis from the Controlled Substances Act, provide detailed banking protections for the cannabis industry, allow military veterans access to state-legal cannabis programs, and expand the ability for cannabis research. Within one year of enactment, the Food and Drug Administration and the Alcohol and Tobacco Tax and Trade Bureau of the Department of the Treasury would be required to introduce federal cannabis regulations.
Industry leaders view the Bill as a promising development in the progress of much needed federal reform efforts. Despite the encouraging progress in state legalization measures (NY, VA, and NM have legalized recreational cannabis in 2021), cannabis remains federally illegal under the Controlled Substances Act because it is a Schedule I drug, alongside heroin, LSD, ecstasy, methaqualone, and peyote. According to the CSA, cannabis has “no currently accepted medical use and a high potential for abuse.” This state / federal legalization conflict has long been a thorn in the side of the legal cannabis community, causing headaches for businesses operating in compliance with state law by creating roadblocks for banking, prohibiting interstate commerce (even between two legal cannabis states that share a border), limiting tax deductions, and preventing research by universities and private labs who receive federal money.
Unfortunately, the new measure does not include social justice provisions to address the harms and inequities caused by cannabis prohibition and the so-called “war on drugs.” This will surely be an avenue for criticism of the measure, even by pro-cannabis legislators. Back in December, the House passed the Marijuana Opportunity, Reinvestment, and Expungement Act (228 to 164), which contained social justice provisions. A small number of Republicans (not including Rep. Joyce) voted in support of the MORE Act. After the new Congress was seated in January of 2021, the House made progress in April by passing the Secure and Fair Enforcement Banking Act of 2021 (321-101). The SAFE Banking Act had clear bipartisan support; 106 Republicans (about 50% of the caucus) voted with 215 Democrats in favor. Sen. Majority Leader Chuck Schumer (NY), Sen. Cory Booker (D-NY), Ron Wyden (D-OR) have also been working on what is rumored to be a more comprehensive cannabis reform bill. Sen. Schumer pledged to take on federal cannabis legalization over three months ago.
All of these efforts indicate that federal cannabis reform is certainly building momentum with the current Congress. Ultimately, what will make the passage of reform difficult is that 60 votes in the Senate will likely be required for passage of any law. Although there is growing bipartisan support for reform, this remains an uphill battle for pro-cannabis legislators. Nevertheless, businesses waiting for the federal status of cannabis to change before entering the market should closely monitor the progress of federal cannabis reform. Those businesses should also speak with trusted counsel about how to prepare for the eventual passage of reform and de-scheduling of cannabis.
Welcome to the Cannabis Business Legal News blog where attorneys from Amundsen Davis blog about all things cannabis business and legal news related.
- Historic Cannabis Rescheduling on the Horizon? It's Up to the DEA Now
- FDA Issues First Ever Guidance for Research of Psychedelics
- Movement on the SAFE Banking Act? The Senate is Talking the Talk, but Not Ready to Walk the Walk
- The Federal Government & CBD – What the FDA is Happening?
- Illinois Lawmaker Introduces Legislation to Legalize Psychedelic Therapy Programs
- Illinois Set to Roll out New Cannabis Retail License Applications and Lottery in Early 2023
- Could a Small Town in Pennsylvania Force Congress to Deschedule Cannabis?
- No April Fool’s Joke: The MORE Act was Just Passed by the House
- Significant Increase in Production of Cannabis and Psychedelics for Research Proposed by the DEA for 2022 – What You Need to Know Now
- Protecting Your Cannabis Business from the Trappings of the Telephone Consumer Protection Act
- August 2023
- May 2023
- January 2023
- November 2022
- April 2022
- October 2021
- August 2021
- July 2021
- May 2021
- December 2020
- April 2020
- December 2019
- November 2019
- August 2019
- June 2019
- May 2019
- April 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- June 2018
- May 2018
- July 2016